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Hypothalamic neuropeptide Y (NPY) has been implicated in the regulation of energy balance and reproduction,
and chronically elevated NPY levels in the hypothalamus are associated with obesity and reduced reproductive
function. However, it is not known which one of the five cloned Y receptors mediates these effects. Here we
show that crossing the Y4 receptor knockout mouse (Y4−/−) onto the ob/ob background restores the reduced
plasma testosterone levels of ob/ob mice as well as the reduced testis and seminal vesicle size and
morphology to control values. Fertility in the sterile ob/ob mice was greatly improved by Y4 receptor deletion,
with 100% of male and 50% of female Y4−/−,ob/ob double knockout mice producing live offspring.
Development of the mammary ducts and lobuloalveoli was significantly enhanced in pregnant Y4−/− and
Y4−/−,ob/ob females. Consistent with the improved fertility and enhanced mammary gland development,
gonadotropin releasing hormone (GnRH) expression was significantly increased in Y4−/− and Y4−/−,ob/ob
animals. Y4−/− mice displayed lower body weight and reduced white adipose tissue mass accompanied by
increased plasma levels of pancreatic polypeptide (PP). However, Y4 deficiency had no beneficial effects to
reduce body weight or excessive adiposity of ob/ob mice. These data suggest that central Y4 receptor signaling
specifically inhibits reproductive function under conditions of elevated central NPY-ergic tonus.
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Hypothalamic neuropeptide Y (NPY) is a major central
regulator of sexual behavior and reproductive functions.
Intracerebroventricular (ICV) administration of NPY to
sex steroid-primed ovariectomized (OVX) rats increases
secretion of luteinizing hormone (LH), and stimulates
secretion of gonadotropin releasing hormone (GnRH)
from the median eminence in vitro, functions that prob-
ably mediate the preovulatory surge of LH release
(Sabatino et al. 1990; Urban et al. 1996; Jain et al. 1999).
In contrast, when centrally administered to sex steroid-
deficient OVX rats, or to intact male and female rats,
NPY markedly inhibits reproductive function (Clark et
al. 1985; Reznikov and McCann 1993; Xu et al. 1993;
Pierroz et al. 1996). This includes decreased GnRH re-
ceptor concentration in the pituitary gland, reduced pi-
tuitary weight, and decreased plasma concentrations of
prolactin, LH, follicle stimulating hormone (FSH), and
testosterone. Testicular and seminal vesicle or ovarian
weights are also reduced, and sexual maturation and es-
trous cyclicity in female rats is disrupted, leading to
drastic suppression of male and female copulatory be-
havior (Clark et al. 1985; Reznikov and McCann 1993;
Xu et al. 1993; Pierroz et al. 1996). These inhibitory ef-
fects of NPY on reproductive function probably contrib-
ute to the decreased fertility observed under conditions
of negative energy balance, such as food restriction,
heavy exercise, lactation, and insulin-dependent diabe-
tes mellitus, all of which are associated with elevated
hypothalamic NPY expression (Aubert et al. 1998;
Krysiak et al. 1999). In this way NPY coordinates energy
availability with reproduction, inhibiting procreation
during unfavorable metabolic conditions.
Interestingly, obesity is also associated with reproduc-
tive defects and reduced fertility (Caprio et al. 2001). Ge-
netically obese ob/ob mice lack functional leptin, the
hormone produced mainly by white adipose tissue. This
mutation not only leads to hyperphagia, massive obesity,
and the associated hormonometabolic defects (hypercor-
ticosteronemia, hyperinsulinemia, hyperglycemia, and
insulin resistance), but also leads to infertility due to
insufficient hypothalamo-pituitary-gonadal drive, under-
development of reproductive organs, and impaired sper-
matogenesis (Caprio et al. 2001). In ob/ob mice, the lack
of leptin-mediated inhibition of NPY expression and se-
cretion in the hypothalamus (Stephens et al. 1995;
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Schwartz et al. 1996; Widdowson and Wilding 2000)
leads to chronically elevated hypothalamic NPY-ergic
activity. This secondary effect of leptin deficiency con-
tributes to many of the associated defects. Indeed, treat-
ment of ob/ob mice with leptin reduces NPY mRNA
expression and peptide levels in the hypothalamus, re-
duces the hyperphagic, obese phenotype, and also re-
stores fertility of male and female mice by improved
function of the hypothalamo-pituitary-gonadal axis (Ste-
phens et al. 1995; Chehab et al. 1996; Mounzih et al.
1997). Importantly, food restriction that produced a de-
gree of weight loss similar to that produced by leptin
treatment did not reduce central NPY expression and did
not restore fertility in ob/ob mice (Mounzih et al. 1997).
Further evidence that elevated central NPY-ergic tonus
mediates the pathology of leptin deficiency is that most
of the defects of ob/ob mice, including infertility, are
attenuated or normalized when crossed onto NPY
knockout mice (Erickson et al. 1996).
The various functions of NPY are mediated by the Y
receptor gene family, consisting of at least five distinct
members (Y1, Y2, Y4, Y5, and y6) (Blomqvist and Herzog
1997). In addition to their involvement in reproduction
and energy homeostasis, these Y-receptors when acti-
vated by their ligands, NPY, peptide YY (PYY), and
pancreatic polypeptide (PP), can also modulate other im-
portant physiological functions, including circadian
rhythms, gastrointestinal motility, memory, anxiety,
nociception, and blood pressure (Hokfelt et al. 1998;
Gehlert 1999; Kalra et al. 1999). Messenger RNAs for Y1,
Y2, and Y5 are widely distributed throughout the brain
(Naveilhan et al. 1998; Parker and Herzog 1999). In con-
trast, the Y4 receptor is predominantly expressed in the
periphery including tissues such as the pancreas, intes-
tine, colon, heart, and liver (Bard et al. 1995; Lundell et
al. 1995). However, significant amounts of Y4 mRNA
and specific binding sites have also been found in key
areas of the hypothalamus such as the paraventricular
nucleus and in certain brainstem nuclei including the
area postrema and the nucleus tractus solitarius (Parker
and Herzog 1999; Larsen and Kristensen 2000). Y recep-
tors show very low primary amino acid sequence iden-
tity, yet surprisingly exhibit very similar pharmacology,
with NPY and PYY being equipotent at all receptor sub-
types. PP has high affinity only for the Y4 receptor, and
in some species it also has moderate affinity for the Y1
and Y5 receptors.
Although NPY is known to be involved in numerous
physiological and pathophysiological processes, the
clarification of the functions of specific Y receptor sub-
types has been severely hampered by the lack of subtype-
selective agonists and antagonists. The functions of the
Y4 receptor subtype and its high-affinity agonist PP are
among the less well understood of the Y receptor family.
However, it was recently demonstrated that ICV admin-
istration of the Y1 antagonist and Y4 agonist 1229U91
(Schober et al. 1998) to estrogen-primed OVX or intact
male rats rapidly increased FSH and/or LH secretion (Jain
et al. 1999; Raposinho et al. 2000). These effects were
attributed to Y4 activation by pharmacological analysis
of other partial Y4 agonists (Raposinho et al. 2000), and
also because rat PP, which is specific for the rat Y4 re-
ceptor, induced a similar profile of LH secretion in es-
trogen-primed OVX rats (Jain et al. 1999). Since PP is not
expressed within the brain and does not cross the blood–
brain barrier, it is possible that instead NPY acts as a
central, albeit lower-affinity ligand for the hypothalamic
Y4 receptor when expression levels are sufficiently high
to agonize this receptor. We therefore hypothesized that
under conditions of high hypothalamic NPY levels, as in
energy deficit or leptin-deficient obesity, NPY could
modulate reproductive functions through activation of
Y4 receptors. To test this hypothesis we generated Y4
receptor knockout mice and crossed them with the obese
ob/ob mutant strain and analyzed the effects on energy
homeostasis and fertility.
Results
Generation of Y4 receptor knockout mice
A targeting vector for the Y4 receptor gene was designed
which allowed the production of both germ-line (Y4−/−)
and conditional (Y4lox/lox) knockout mice (Fig. 1A). A
cassette containing the neomycin resistance gene (Neo)
flanked on either side by a 34 bp-long Cre-recombinase
recognition (loxP) site oriented in the same direction was
placed downstream of the Y4 receptor gene. A third loxP
sequence was inserted into intron I of the Y4 receptor
gene (Fig. 1A). Mouse embryonic stem (ES) cells from the
strain 129/SvJ were transfected and selected under stan-
dard conditions. Positively targeted clones were identi-
fied by Southern analysis. Hybridization with the Neo
gene was used to verify single integration (data not
shown).
Two positive ES cell clones for the Y4 receptor con-
struct were injected into blastocysts originating from
C57BL/6 mice and implanted into pseudopregnant mice.
Offspring with the highest percentage of agouti coat
color were crossed with X chromosome-linked, oocyte-
specific Cre-recombinase-expressing C57BL/6 mice
(Schwenk et al. 1995) to obtain either heterozygotes car-
rying the floxed gene (conditional, Y4+/lox), or heterozy-
gotes carrying the Cre-recombinase gene and having the
floxed gene already deleted (germ line Y4+/−). DNA iso-
lated from tail tips was used in Southern blot analysis
(EcoRI) to confirm correct integration and/or modifica-
tion of the targeted allele (Fig. 1B). Absence of the Y4
gene in Y4−/− mice was confirmed by Southern analysis
(EcoRV) using a DNA fragment specific for the Y4 recep-
tor coding sequence (Fig. 1C). All further mice generated
were maintained on this 50% C57BL/6 − 50% 129/SvJ
background.
Breeding of heterozygous germ-line knockout animals
produced no significant deviation from the expected
Mendelian ratio of genotypes (25:50:25). Y4−/− animals
breed normally; however, the gender ratio in Y4−/− off-
spring is significantly shifted to a greater proportion of
females (56%, n = 112, P < 0.01). Interestingly, male
Y4−/− mice show very aggressive behavior with increased
Sainsbury et al.
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Figure 1. Generation of Y4 receptor knockout mice. (A) Targeting vector design and screening strategy. Small arrows indicate the position and orientation of oligonucleotides
used in the PCR analysis, and bars indicate the position of probes used for Southern analysis of genomic DNA from targeted ES cells as well as knockout animals. (B,C) Southern
analysis of genomic DNA isolated from conditional and germ line Y4 receptor knockout mice cut with EcoRI or EcoRV, using probes A and B, respectively.
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incidences of fighting between littermates causing inju-
ries. Female Y4−/− mice behave normally in early life and
adulthood, but show aggressive behavior and occasion-
ally kill littermates after 20–24 wk of age
Reduced body weight and increased plasma
pancreatic polypeptide levels in Y4−/− mice
At 4 wk of age, the body weights of female Y4−/− mice
were significantly less than that of Y4+/+ controls. The
body weights of male Y4−/− mice at that age were not
significantly different from control values. Both genders
of Y4−/− mice, particularly males, gained significantly
less weight over the next 12 wk of monitoring (Fig. 2).
Consistent with this is the finding that the 24-h food
intake of male but not female Y4−/− mice was signifi-
cantly less than that of wild-type controls (4.42 ± 0.10 vs.
5.64 ± 0.30 g at 8 wk, P < 0.001, and 4.18 ± 0.10 vs.
4.70 ± 0.28 g at 12 wk, P < 0.05, means ± SEM of 9–27
mice per group).
Plasma levels of PP (the endogenous high-affinity li-
gand for Y4 receptors) were increased by two- to three-
fold in both male and female Y4−/− mice compared to
wild-type controls (Fig. 3A), with male mice having sig-
nificantly greater basal plasma PP concentrations than
females (Fig. 3A, P < 0.0001). The combined mass of
white adipose tissue (WAT) deposits was significantly
lower in Y4−/− mice than in wild types, significantly so in
male mice (Fig. 3B). Interestingly, when individual WAT
deposits were investigated, mesenteric WAT was the
major contributor to decreased WAT weight in male and
female Y4−/− mice (0.65 ± 0.06 vs. 0.84 ± 0.05 % of body
weight in male mice, P < 0.01, and 0.53 ± 0.06 vs.
0.76 ± 0.05 % of body weight in female mice, P < 0.05,
means ± SEM of 28–37 mice per group), with no signifi-
cant effect of Y4 deletion on the weight of epididymal or
periovarian WAT, nor on inguinal or retroperitoneal
WAT (data not shown). Y4−/− mice showed no significant
difference from wild types with respect to plasma con-
centrations of leptin, insulin, glucose, or testosterone
but had a tendency to reduced levels of corticosterone
(P = 0.055; Table 1). The weights (as a percentage of body
weight) of the pancreas, stomach, small intestine, liver,
kidney, and testis or ovary of Y4−/− mice were not sig-
nificantly different from those of wild-type controls
(Table 1).
Decreased corticosteronemia in Y4−/−,ob/ob double
knockout mice
Male and female heterozygous (OB/ob) mice on a
C57BL/6 background were crossed with Y4−/− animals.
Double heterozygous (Y4+/−,OB/ob) animals were
Figure 2. Body weight of Y4 receptor knockout mice. Body
weight of male Y4−/− () and female Y4−/− () mice compared
with combined wild-type (Y4+/+) and heterozygous (Y4+/−) con-
trols (males , females ). Values are means ± SEM of 20–32
mice per group. *P < 0.05 and **P < 0.01 versus curve for same-
sex controls.
Figure 3. Plasma pancreatic polypeptide concentrations and
adiposity of Y4 receptor knockout mice. (A) Plasma levels of
pancreatic polypeptide, and (B) weight (as percent of body
weight) of combined right inguinal, right epididymal or peri-
ovarian, right retroperitoneal, and mesenteric white adipose tis-
sue (WAT) of germ line Y4−/− mice (filled bars) versus Y4+/+
control mice (open bars). Values are means ± SEM of 15–31 mice
per group. (*) P < 0.05 versus same-sex Y4+/+ controls.
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crossed again to subsequently obtain all of the nine pos-
sible genotypes. The food intake of male and female
Y4−/−,ob/ob double knockout mice was not significantly
different from that of the ob/ob mice (data not shown),
suggesting that Y4 receptors are not directly involved in
the regulation of feeding behavior in these animals. At 4
wk of age, male and female Y4−/−,ob/ob double knockout
mice had body weights similar to those of the ob/ob
mice, but male double knockouts gained significantly
more weight in the following 12 wk of monitoring com-
pared to ob/ob controls (Fig. 4). A tendency for increased
body weight was also apparent in Y4−/−,OB/ob males
compared to OB/ob or wild-type controls (Fig. 4). Female
Y4−/−,ob/ob double knockout mice showed no signifi-
cant difference from ob/ob mice with respect to body
weight over the 12 wk of monitoring (data not shown).
There was a significant interaction effect between Y4
and leptin deficiency on WAT mass (P < 0.01). Whereas
Y4 deficiency significantly increased the WAT mass of
lean OB/ob mice, the increased WAT mass of obese ob/
ob mice was not further increased in Y4−/−,ob/ob double
knockout mice (Table 2). Insulinemia and glycemia of
ob/ob mice were significantly elevated over wild-type
values, and the absence of Y4 receptors in Y4−/−,ob/ob
double knockout mice had no significant effect on these
parameters (Table 2). Plasma levels of PP in ob/ob mice
were strongly reduced compared to wild-type mice (Fig.
3A). Y4 deletion restored plasma PP levels in Y4−/−,ob/ob
mice to values not significantly different from those of
control mice (Fig. 3A; Table 2). Furthermore, the hyper-
corticosteronemia of ob/ob mice was significantly at-
tenuated in Y4−/−,ob/ob double knockout mice (Fig. 5A).
Increased fertility in Y4−/−,ob/ob double
knockout mice
The most profound effects of Y4 deletion on ob/ob mice
were observed upon reproductive functions. Figure 5B–D
shows plasma testosterone levels, and the absolute
weight of testis and seminal vesicle of heterozygous OB/
ob and homozygous ob/ob mice with or without Y4 re-
ceptor deletion. OB/ob mice that were Y4+/+ showed no
significant difference from wild-type mice with respect
to any of the parameters shown in Figure 5, nor in any
other of the parameters measured (see Materials and
Methods), with the exception of a significant increase in
relative and absolute hepatic weight. In ob/ob mice,
plasma testosterone concentrations were markedly de-
pressed compared to wild-type or heterozygous OB/ob
animals, in keeping with the significantly reduced
weight of testis and seminal vesicle in these animals
(Fig. 5B–D). Notably, crossing the Y4 receptor knockout
onto ob/ob mice significantly increased the plasma tes-
tosterone levels of males compared to ob/ob animals,
and significantly increased absolute testis and seminal
vesicle weights to values not significantly different from
those of OB/ob or wild-type control mice (Fig. 5B–D).
The observed increase in body weight of male Y4−/−,ob/
ob compared to ob/ob mice (Fig. 4) is probably in part
due to this increase in plasma testosterone levels. Figure
6 shows the improvement in testis and seminal vesicle
size in ob/ob mice with Y4 receptor deficiency, since the
organs of Y4−/−,ob/ob double knockout mice resembled
those of wild types. Under light microscopy, the mor-
phology of testis and seminal vesicle from Y4−/−,ob/ob
double knockout mice was similar to that of wild-type
Figure 4. Body weight of Y4−/−,ob/ob double knockout mice.
Body weight of male Y4−/−,ob/ob () compared with ob/ob (),
Y4−/−,ob/ob (H17009), OB/ob () and wild-type () mice. Values are
means ± SEM of 20–32 mice per group. *P < 0.05 versus curve
for ob/ob mice.
Table 1. Plasma hormone and metabolite concentrations,
and organ weights in Y4−/− mice
Y4+/+ Y4−/−
Leptin (ng/mL) male 5.3 ± 0.8 4.5 ± 0.8
female 5.7 ± 0.6 5.1 ± 0.7
Insulin (pM) male 110 ± 14 89 ± 10
female 58 ± 7 50 ± 5
Glucose (mM) male 9.9 ± 0.3 10.5 ± 0.5
female 10.0 ± 0.3 10.7 ± 0.3
Corticosterone (ng/mL) male 76 ± 16 57 ± 16
female 165 ± 25 111 ± 15
Testosterone (nM) male 10.4 ± 3.3 15.9 ± 4.3
female ND ND
Gonad weight (% BWt) male 0.75 ± 0.03 0.80 ± 0.03
female 0.08 ± 0.01 0.07 ± 0.01
Data are means ± SEM of 7–21 mice per group. ND, Not deter-
mined.
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organs. Leydig cell and mature sperm densities were in-
creased over ob/ob levels (Fig. 6).
These changes were also reflected in fertility. To test
the fertility of male Y4−/−,ob/ob double knockouts, they
were paired with female Y4−/−,OB/ob mice which were
previously proven to be fertile by their ability to produce
live offspring with male wild-type mice. The same strat-
egy was applied to test fertility in female Y4−/−,ob/ob
mice. For comparison, male or female ob/ob mice were
paired with fertile OB/ob animals of the opposite sex.
All eight breeding pairs consisting of Y4−/−,ob/ob males
and Y4−/−,OB/ob females produced live offspring. In con-
trast, only one of the eight ob/ob males was able to pro-
duce offspring. Interestingly, four of the eight Y4−/−,ob/
ob females were able to establish pregnancies and deliver
live pups, two of them twice, whereas none of the eight
ob/ob females tested were capable of doing so.
To identify possible abnormalities in estrous cycles,
estrous cyclicity was assessed by daily vaginal smear cy-
tology in Y4−/−, ob/ob, and Y4−/−,ob/ob mice. Y4−/− ani-
mals exhibited normal vaginal opening and onset of nor-
mal estrous cyclicity, with proestrous, estrous, metes-
trous, and diestrous stages all present, and a cycle length
of 4–5 d. In ob/ob animals, the vaginal opening was very
small and a diestrous-like swab was observed until 9 wk
of age, when cycles lasting from 11 to 15 d commenced.
An estrous-like cytology lasted 6–8 d and was character-
ized by a small number of poorly clumped superficial
epithelial cells, large quantities of cellular debris, and
increased mucous. In fertile Y4−/−,ob/ob animals, the
vaginal opening was complete by 9 wk of age but the
total cycle length remained extended, from 11 to 16 d
with an estrous lasting up to 7 d. This extended estrous
showed plentiful clumped superficial epithelial cells,
and the female was receptive in this state and mating
could produce a pregnancy. Infertile Y4−/−,ob/ob animals
showed a persistent small vaginal orifice and vaginal cy-
tology similar to ob/ob animals, characterized by an ab-
Figure 5. Effect of Y4 deletion on plasma corticosterone and testosterone levels, and testis and seminal vesicle weight in mice with
an ob/ob background. Plasma concentrations of (A) corticosterone and (B) testosterone (C) testis weight and (D) seminal vesicle weight
of Y4+/+ mice (open bars) and Y4−/− mice (filled bars) on an OB/ob or ob/ob background. Values are means ± SEM of 6–17 mice per
group. *P < 0.05, **P < 0.01, and ***P < 0.001 for the comparison indicated by horizontal bars.
Table 2. Weight of white adipose tissue deposits, and plasma hormone and metabolite concentrations in male Y4−/−,ob/ob
double knockout mice and controls
OB/ob Y4−/−OB/ob ob/ob Y4−/−ob/ob
Sum of WAT (%) 2.48 ± 0.22 3.51 ± 0.33a 8.19 ± 0.29c 7.51 ± 0.30c
Insulin (pmol/L) 89 ± 16 201 ± 41 7420 ± 2230c 9800 ± 2300b
Glucose (mmol/L) 10.5 ± 0.5 12.8 ± 0.7 18.3 ± 4.0b 13.7 ± 2.0
PP (nmol/L) ND ND 1.18 ± 1.04 6.45 ± 1.70d
Data are means ± SEM of 6–18 mice per group. Sum of WAT, combined weight of right inguinal, right epididymal or pcriovarian, right
retroperitoneal, and mesenteric white adipose tissue as a percent of body weight; PP, pancreatic polypeptide; ND, not determined.
aP < 0.05, bP < 0.01, cP < 0.001 versus OB/ob control mice. dP < 0.05 versus ob/ob mice.
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sence of large numbers of clumped superficial epithelial
cells during an extended estrous. Ovarian morphology of
the four different genotypes was also assessed (Fig. 7).
Hematoxylin/eosin-stained sections show normal his-
tology in Y4−/− and wild-type (WT) mice, characterized
by the presence of multiple primary and secondary fol-
licles and well developed corpora lutea. Ovaries from
ob/ob mice, taken during their extended estrous, showed
very few primary or secondary follicles. Many large
empty follicles were seen and no proper developed cor-
pora lutea were present. Loss of Y4 on the ob/ob back-
ground resulted in an increase in the number of corpora
lutea and primary and secondary follicles, the extent of
which was variable among individuals, consistent with
the partial rescue of fertility in this genotype. Large
empty follicles, characteristic of the ob/ob genotype,
continued to be present in all animals.
Mammary gland development examined in Y4+/+,
Y4−/−, ob/ob, and Y4−/−,ob/ob double knockout females
showed significant changes (Fig. 8). In Y4−/− females,
ductal development proceeded normally at puberty to
Figure 6. Effects of Y4 receptor deletion on testis and seminal
vesicle morphology in Y4−/− and Y4−/−,ob/ob double knockout
mice. Lower panels show hematoxylin/eosin-stained sections
from testis of the indicated genotypes. Three seminiferous tu-
bules were chosen that displayed different stages of sperm pro-
duction. Leydig cells are seen at the center of the panels. Origi-
nal magnification, 200×.
Figure 7. Effects of Y4 receptor deletion on ovary morphology.
Hematoxylin/eosin-stained sections of ovaries at estrous from
wild-type (WT) and Y4−/− animals, or extended estrous in ob/ob
and Y4−/−, ob/ob animals. Original magnification, 100×.
Figure 8. Effect of Y4 receptor deletion on mammary gland
development in Y4−/− and Y4−/−,ob/ob double knockout mice.
Whole mounts (5× original magnification) and corresponding
hematoxylin/eosin-stained histology (insets, 100× original mag-
nification) of the 4th inguinal mammary gland from females of
the indicated genotypes, either virgins or after pairing with a
fertile male (mated). Animal age is indicated in weeks (w) and
reproductive state for the mated group as days of pregnancy (dp),
days postpartum (pp), or nulliparous (np).
Y4 receptor KO rescues fertility in ob/ob mice
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produce a branched ductal tree of a complexity seen in
mixed 129/SvJ-C57BL/6 animals. During pregnancy,
lobuloalveolar development was accelerated as demon-
strated by the significantly increased lobuloalveolar con-
tent of the glands at day 16 of pregnancy (18.74 ± 0.66%
area of 4th gland in Y4−/− animals compared to 15.79 ±
0.86% in wild-type animals, P < 0.05, means ± SEM of 5
mice per group) (Fig. 8). In virgin ob/ob animals, no duc-
tal development occurred, with the exception of one ani-
mal from the mated group which showed increased duc-
tal development. However, this development was abnor-
mal, as the gland consisted of only finely branched ducts
without the extensive underlying network of major
ducts that were seen in wild-type animals (Fig. 8), con-
sistent with development during a prior pseudo- or
failed-pregnancy. In nulliparous Y4−/−,ob/ob females, the
loss of Y4 failed to rescue the development of the mam-
mary ductal tree and the gland remained in the prepu-
bescent state, consisting of a few short ducts emanating
from the sinus beneath the nipple (Fig. 8). In Y4−/−,ob/ob
females that experienced a full-term pregnancy, the de-
gree of mammary development varied. Some females
showed minimal ductal elongation and produced a few
sparse lobules, while others produced large areas of lob-
ules that showed the presence of milk and oil droplets
(Fig. 8). However, irrespective of the histological appear-
ance of these glands, the mothers were incapable of en-
suring survival of the pups.
Altered neuropeptide expression in Y4−/−,ob/ob double
knockout mice
To assess possible central mechanisms for changes in
energy balance and reproductive function in Y4−/− and
Y4−/−,ob/ob mice, we measured central expression of
peptides or their precursors known to regulate energy
balance [NPY, agouti-related peptide (AgRP), proopio-
melanocortin (POMC), and cocaine and amphetamine-
regulated transcript (CART)] (Kalra et al. 1999) as well as
reproduction (NPY and GnRH) (Pierroz et al. 1996; Jain
et al. 1999). In situ hybridization was performed on co-
ronal brain sections obtained from male mice, using spe-
cific radiolabeled antisense DNA oligonucleotides for
these mRNAs. Background labeling was uniform and
never exceeded 5% of specific signal.
Y4−/− mice did not display altered NPY, AgRP, POMC,
or CART mRNA levels in any area investigated (Table
3). Typically, increased NPY and AgRP mRNA expres-
sion accompanied by decreased POMC and CART
mRNA levels were observed in the arcuate nucleus of
ob/ob mice. Notably, Y4−/−,ob/ob double knockout mice
displayed significantly lower NPY and AgRP levels than
ob/ob animals, although the levels were still markedly
augmented compared to wild-type animals (Table 3).
Most importantly however, Y4−/− mice as well as Y4−/−,
ob/ob double knockouts showed significantly increased
GnRH mRNA levels in forebrain neurons compared to
wild-type values (Table 3; Fig. 9). These data are consis-
tent with the enhanced reproductive function observed
in Y4−/−,ob/ob mice, and suggest that the increase in
GnRH expression caused by removal of Y4 receptor sig-
naling is a major contributor to the establishment of fer-
tility in male ob/ob mice. This hypothesis is further sup-
ported by results obtained from another Y receptor
knockout model generated by us (Baldock et al. 2002). In
Y2−/− mice, the lack of Y2 receptors did not alter the
expression levels of GnRH mRNA in forebrain neurons
compared to wild-type values (104 ± 2.11%, n = 5,
P < 0.002). More importantly, Y2−/−,ob/ob double knock-
out animals were completely infertile, as none of the six
male or four female mice tested produced any offspring.
Discussion
This study shows that the infertility of leptin-deficient
ob/ob mice involves signaling through Y4 receptors,
since crossing our Y4 receptor knockout onto the ob/ob
strain conferred the ability to produce live births in
breeding pairs consisting of male or female Y4−/−,ob/ob
double knockout mice. This was accompanied by signifi-
Table 3. Expression levels NPY, AgRP, POMC, and CART mRNAs
mRNA wild type Y4−/− ob/ob Y4−/−, ob/ob
Neurons in the arcuate nucleus
NPY 100 ± 5.48 (5) 98 ± 3.22 (5) 178 ± 7.44 (5)c 155 ± 0.57 (3)c,d
AgRP 100 ± 4.70 (4) 95 ± 3.65 (5) 167 ± 7.28 (5)c 136 ± 8.38 (3)b,e
POMC 100 ± 3.91 (5) 99 ± 4.84 (4) 33 ± 3.00 (5)c 39 ± 0.45 (3)c
CART 100 ± 2.21 (5) 103 ± 2.67 (5) 23 ± 1.26 (5)c 26 ± 3.27 (4)c
GnRHI neurons in the forebrain
Med. Sept. n. 100 ± 6.63 (5) 123 ± 2.10 (5)a 104 ± 4.33 (5) 122 ± 8.81 (4)a,d
Preopt. a. 100 ± 6.42 (5) 120 ± 4.33 (5)a 103 ± 4.62 (5) 120 ± 3.85 (4)a,d
Neurons in the cortex
NPY 100 ± 4.20 (5) 98 ± 5.29 (5) 98 ± 6.04 (5) 97 ± 7.72 (4)
Neurons in the paraventricular nucleus
CART 100 ± 3.36 (4) 102 ± 4.24 (5) 96 ± 2.38 (5) 101 ± 3.10 (3)
Data represent mean labeling intensity of neurons given as percentage of wild type ± SEM (number of animals); aP < 0.05, bP < 0.01 and
cP < 0.001 versus wild-type; dP < 0.05 and eP < 0.01 versus ob/ob. Med. Sept. n. = medial septal nucleus; Preopt. a. = preoptic area.
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cant improvements in gonadotropic function in male
mice, partial restoration of estrous cycling in females,
and increased GnRH expression in the forebrain, in keep-
ing with mediation by the brain centers that regulate
reproduction. Since PP, the only known endogenous
high-affinity Y4 receptor agonist, does not cross the
blood–brain barrier and is not found in the brain, we
propose that the high hypothalamic NPY levels present
in ob/ob mice are sufficient to inhibit reproductive func-
tions by agonism of central Y4 receptors. In support of
this hypothesis, crossing the ob/ob strain onto NPY-de-
ficient mice has also been shown to rescue fertility in
male and female NPY−/−,ob/ob double knockout mice
(Erickson et al. 1996). Furthermore, fasting of ob/ob ani-
mals, which reduces their body weight without affecting
the high NPY levels, does not restore fertility (Mounzih
et al. 1997).
Although Y4 receptor deletion in ob/ob mice can re-
store fertility and lead to improved mammary gland de-
velopment, pups born of Y4−/−,ob/ob females die from
dehydration and/or starvation within 1–2 d after birth.
The primary cause appears to be failed lactogenesis, but
could also be due to the defective maternal behavior of
these females as seen by the scattering of pups in the
cage rather than collection within the nest. A similar
situation is found in leptin-treated female ob/ob mice,
which can conceive and deliver live pups, but also fail to
lactate (Chehab et al. 1996). Furthermore, mice with
knockout of genes involved in prolactin release or the
prolactin signaling pathway show a similar lactational
and behavioral defect (Liu et al. 1997; Ormandy et al.
1997; Wynick et al. 1998). This suggests that although
Y4 receptor deletion can partially restore gonadotropic
function in ob/ob females, pituitary prolactin release
may only be restored to a level sufficient to maintain the
corpus luteum but insufficient to allow lactogenesis and
correct maternal behavior. Two Y4−/−,ob/ob mothers had
second litters and both again failed to lactate. This raises
the possibility that in addition to leptin’s hypothalamic
action to reduce NPY signaling, binding to its receptor in
the mammary gland may also be required for full devel-
opment and normal onset of lactogenesis.
In addition to lack of leptin, the genetic background of
C57BL/6 ob/ob mice has also been considered to con-
tribute to infertility. Male animals deficient in the leptin
gene on a mixed C57BL/6J-BALB/cJ genetic background
showed improved fertility, with 41% being able to pro-
duce offspring, although none of the ob/ob females on
this genetic background were able to do so (Ewart-
Toland et al. 1999). It has been suggested that inheri-
tance of so-called modifier genes is responsible for the
improvement in male fertility in these animals. Interest-
ingly, one of the loci found to be associated with high
testosterone levels in the present study (D14MIT113) is
very close to the location of the Y4 receptor gene
(D14MIT14), making the Y4 receptor a strong candidate
for such a modifier gene. In our studies, the improved
fertility of Y4−/−,ob/ob mice was not due to breeding
onto the mixed C57BL/6-129/SvJ background, because
our ob/ob control mice on the same genetic background
were effectively sterile by comparison.
Analysis of our male and female Y4−/− mice also
showed a several-fold increase in plasma concentrations
of PP compared to wild-type values. PP is released from
pancreatic F cells in response to stimuli such as food
intake and hypoglycemia, mainly by vagal muscarinic
activation (Schwartz 1983; Havel et al. 1993). It is
thought to act on Y4 receptors in the brain stem acces-
sible to plasma-borne factors to enhance digestive events
such as gastric secretion, motility, and emptying by sub-
sequent activation of vagal cholinergic pathways (Mc-
Tigue et al. 1997). It is therefore possible that the loss of
Y4 receptor function contributed to the reduced body
weight gain and reduced adiposity in Y4−/− mice by an
inefficiency of nutrient uptake during digestion. It is also
possible that the reduced body weight of Y4−/− mice was
mediated by the high plasma PP concentrations acting
on other peripheral Y receptors besides Y4. In support of
this, PP transgenic mice, which have a 20-fold increase
in plasma PP levels, have a metabolic phenotype similar
to that of our Y4−/− mice. This includes reduced food
intake, body weight, and fat mass, as well as reduced
glucose-induced insulin secretion and gastric emptying,
with effects more evident in male compared to female
transgenic mice (Ueno et al. 1999). It appears unlikely
that changes in hypothalamic neuropeptide expression
are involved in the manifestation of the reduced body
weight in Y4−/− mice, because the expression levels of
the orexigenic and anorexic peptides (NPY, AgRP,
POMC, and CART) were no different in Y4−/− mice com-
pared to controls. In ob/ob mice, Y4 deficiency increased
plasma PP levels from the low levels characteristic of
congenitally obese rodents (Jia and Taylor 1984) to levels
Figure 9. Effect of Y4 receptor deletion on GnRH mRNA levels
in neurons of the medial septal nucleus. High-power bright-field
photomicrographs of dipped sections obtained from wild-type,
Y4−/−,ob/ob and Y4−/−,ob/ob double knockout mice after in situ
hybridization for GnRH. Bar, 10 µm.
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not significantly different from those of wild-type mice.
However, this increase was probably of insufficient mag-
nitude to reduce the body weight and adiposity of
Y4−/−,ob/ob mice relative to ob/ob mice.
In conclusion, Y4 receptors are specifically involved in
the down-regulation of reproductive function and im-
paired fertility observed in leptin-deficient ob/ob mice.
This is likely to occur by NPY-mediated activation of Y4
receptors in the brain regions that control the gonado-
tropic axis. In contrast, other aspects of obesity in ob/ob
mice, such as defects in lactation, as well as hyperphagia,
hyperinsulinemia, hyperglycemia, and increased fat
mass, are most likely not mediated by Y4 receptor ago-
nism. In normal physiology, the Y4 receptor may con-
tribute to reducing reproductive capacity when hypotha-
lamic NPY expression is increased, such as in food re-
striction, heavy exercise, lactation, and type 1 diabetes
mellitus, representing a possible new target for the treat-
ment of infertility.
Materials and methods
Targeting vector construction and gene disruption
A 129/SvJ mouse genomic BAC library (GenomSystems) was
screened under low stringency for the Y4 receptor gene using a
human Y4 cDNA probe (Lundell et al. 1995). Positively hybrid-
izing clones were isolated and mapped. A 12 kb HindIII frag-
ment and a 4.5 kb SacI fragment were subcloned into pBlue-
script and used to generate the targeting construct. A loxP-
flanked Neo cassette was inserted into the HindIII site
downstream of the Y4 gene and a third loxP sequence was in-
troduced by cloning two complementary 46 mer oligonucleo-
tides into an XbaI site 5 kb upstream of the Y4 receptor gene
initiation codon. A 1.2 kb HindIII/EcoRI fragment 5 to the Y4
targeting construct was used to screen for positively targeted ES
cell clones. Two of these clones were injected into C57BL/6
blastocysts. Chimeric mice were bred either with C57BL/6 mice
to generate heterozygous conditional knockout mice (Y4lox/+) or
with C57BL/6 transgenic animals containing the Cre-recombi-
nase gene under an oocyte-specific promoter to obtain hetero-
zygous germ line Y4 receptor knockout mice (Y4+/−). Breeding
the respective heterozygous mice generated all five possible
genotypes (Y4lox/lox; Y4lox/+; Y4+/+; Y4+/−; Y4−/−). The genotype of
mice was determined by Southern blot analysis as described in
the Results section, and by PCR using oligonucleotide A (5-
ATCCTTCCTGCCTCTATG-3), oligonucleotide B (5-GGA
TAATACC AGCATGGC-3), and oligonucleotide C (5-GCA
TCTGTACTGAGTGGC-3), with 35 cycles of 94°C for 45 sec,
60°C for 1 min, and 72°C for 20 sec.
Measurement of food intake and body weight
Groups of 16–21 animals per genotype originating from 3–4 dif-
ferent breeding pairs were group-housed and fed standard chow.
Body weight was monitored at the same time each week from 4
wk of age onwards. Food intake was measured over 7 d in indi-
vidually-housed mice at 8 and 12 wk of age.
Tissue collection and analysis
At 16–18 wk of age, Y4+/+ and Y4−/− mice derived from crosses of
Y4+/−parents, as well as six of the nine possible genotypes ob-
tained from crosses of double heterozygous animals (Y4+/+,OB/
OB; Y4−/−,OB/OB; Y4+/+,OB/ob; Y4−/−,OB/ob; Y4+/+,ob/ob; and
Y4−/−,ob/ob) were killed by cervical dislocation between 10.00–
15.00 h for collection of trunk blood, and brains and plasma
were immediately frozen and stored at −80°C. Food was re-
moved from cages 1–3 h before death, which occurred within 90
sec of initial handling and removal from cages to avoid time-
related increases in stress hormones (corticosterone) (Sakakura
et al. 1976). White adipose tissue depots (right inguinal, right
epididymal or periovarian, right retroperitoneal, and mesenter-
ic), pancreas, stomach, small intestine, liver, kidney, heart,
ovary, testis, and seminal vesicle were removed and weighed.
For the morphology investigation, the third and fourth inguinal
mammary glands were dissected out, whole-mounted on glass
slides, and fixed in Bouin’s solution. Plasma PP was radioim-
munoassayed using guinea pig anti-rat PP serum and second
Antibody Precipitating System from Linco Research and 125I-PP
(Auspep). Plasma leptin and insulin levels were measured by
radioimmunoassay kits from Linco Research, corticosterone-
mia and plasma testosterone concentrations were measured
with kits from ICN Biomedicals, and glycemia was determined
with a glucose oxidase assay kit (Trace Scientific, Melbourne,
Australia).
In situ hybridization
Coronal brain sections (20 µm) were cut on a cryostat and thaw-
mounted on superfrost slides. The sections were kept desiccated
at −80°C until their use in the respective experiments. Match-
ing sections from the same coronal brain level of knockout and
control mice (4–5 male mice per group) were assayed together,
generally following the method of Young (1989) with slight
variations (Tsunashima et al. 1997). In short, DNA oligonucleo-
tides complementary to mouse NPY (5-GAGGGTCAGTC
CACACAGCCCCATTCGCTTGTTACCTAGCAT-3); mouse
POMC (5-TGGCTGCTCTCCAGGCACCAGCTCCACACAT
CTATGGAGG-3); mouse GnRH (5-CAAACACACAGTCAG
CAGTAGAATGCCGGCCATCAGTTTGAGGATC-3); mouse
CART (5-TCCTTCTCGTGGGACGCATCATCCACGGCAG
AGTAGATGTCCAGG-3); and mouse AGRP (5-AGCTTGCG
GCAGTAGCAAAAGGCATTGAAGAAGCGGCAGTAGCAC-
3) mRNAs were labeled with [35S]thio-dATP (1300 Ci/mmol,
Amersham) by reaction with terminal deoxynucleotidyltrans-
ferase (Roche) and precipitated with ethanol/sodium chloride.
Frozen sections were rapidly immersed in 2% paraformalde-
hyde in 150 mM NaCl and 10 mM phosphate buffer (pH 7.2;
phosphate buffered saline, PBS) for 10 min in an ice bath, rinsed
in PBS, immersed in 0.25% acetic anhydride in 0.1 M triethyl-
amine hydrochloride (pH 8.2 in saline) for 10 min, dehydrated
by ethanol series, and delipidated with chloroform. Air-dried
sections were hybridized at 42°C for 18 h with 30 fmole (0.6 ×
106 cpm) of labeled oligonucleotide probe in 50 µL hybridization
buffer. The hybridization buffer consisted of 50% formamide,
5× SSC (1× SSC is 150 mM NaCl, 15 mM sodium citrate at pH
7.2), 500 µg/mL salmon sperm DNA, 250 µg/mL yeast tRNA, 1×
Denhardt’s solution (0.02% Ficoll, 0.02 % polyvinylpyrrol-
idone, and 0.02% bovine serum albumin), 10% dextran sulfate,
and 20 mM dithiothreitol. Slides were washed four times in
50% formamide in 2× SSC (42°C, 15 min), cooled to room tem-
perature for 30 min, rinsed in 1× SSC, and dipped briefly in
water. Sections were then dipped in 70% ethanol, dried, and
exposed to Kodak Biomax MR films for 1–5 d. Subsequently the
slides were dipped in Kodak NTB-2 photosensitive emulsion
(diluted 1:1 with distilled water), air dried, and exposed for 6 to
14 d. Films and dipped slides were developed with Kodak D19
developer. Sections were counterstained superficially with he-
matoxylin, dehydrated, and coverslipped with Aquamount
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(BDH). The corresponding radiolabeled sense DNAs were used
to exclude nonspecific hybridization of the probe. Sections hy-
bridized with a 50 times excess of unlabeled probe were in-
cluded as further controls in some experiments.
Autoradiographs were scanned, and relative optical densities
(ROD) were measured over the arcuate nucleus, the medial sep-
tal nucleus, or the paraventricular nucleus. Background mea-
sured over white matter was deducted. For evaluation of mRNA
levels in scattered neurons, images from dipped sections were
digitized using a ProgRes 3008 camera (Zeiss) mounted on a
Zeiss Axiophot microscope. Silver grain density over single neu-
rons was evaluated using NIH-Image 1.61 software (written by
Wayne Rasband and available from anonymous FTP at zippy.
nimh.nih.gov).
Histology of mammary gland, vaginal smear, ovary, testis,
and seminal vesicle
Mammary development was investigated using carmine-
stained whole mounts followed by paraffin embedding and
staining of 5-µm sections using hematoxylin/eosin. Lobuloal-
veoli in hematoxylin/eosin-stained sections were quantified us-
ing digital photography and automated area measurement by a
macro running the NIH Image analysis software (http://rsb.
info.nih.gov/nih-image/). The success of lactation and suckling
was assessed by examination of the stomach contents of pups;
milk where present was visible through the skin. Estrous cy-
clicity was studied using DiffQuick staining of vaginal swabs
spread on glass slides. Ovaries were fixed in 4% paraformalde-
hyde and embedded in paraffin before examination of 5-µm he-
matoxylin/eosin-stained sections. For examination of morphol-
ogy, seminal vesicle was separated from the coagulating gland
and cut from the urethra at their junction. The epididymis/vas
deferens was removed from the testis. Testes were fixed in
Bouin’s fixative, transferred to 10% glucose solution, paraffin
embedded, sectioned at 5 µm, and stained with hematoxylin-
eosin.
Statistical analyses
Results for body weight were compared among groups by re-
peated measures ANOVA followed by Fisher’s post-hoc tests.
Differences in food intake were assessed by Student’s t-tests.
Differences between Y4−/− and Y4+/+ mice in tissue and organ
weights and plasma hormone and metabolite concentrations
were assessed by 2-way ANOVA (effect of Y4 deletion and gen-
der, with subsequent Fisher’s post-hoc tests). Comparison of
these parameters among male Y4+/+,OB/OB; Y4−/−,OB/OB;
Y4+/+,OB/ob; Y4−/−,OB/ob; Y4+/+,ob/ob; and Y4−/−,ob/ob mice
was made by 2-way ANOVA (effect of Y4 deletion and ob mu-
tation). When the Y4 or Y4*ob interaction effect was significant,
Fisher’s post-hoc tests were used to locate significant differ-
ences between groups. Alterations in neuronal neuropeptide
mRNA expression were assessed be ANOVA with Fisher’s post-
hoc tests. StatView version 4.5 (Abacus Concepts) was used for
all statistical analyses, and P < 0.05 was accepted as being sta-
tistically significant.
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